Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

類似資料

• Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement
  著者:: Shimada, Midori, 等
  出版事項: (2016)
• Programmed death ligand-1 inhibitors potentially carry a lower risk of pneumonitis compared with programmed death-1 inhibitors in patients with non-small cell lung cancer
  著者:: Fukuda, Minoru, 等
  出版事項: (2018)
• Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer
  著者:: Mori, Mio, 等
  出版事項: (2019)
• Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
  著者:: Ikeda, Takaya, 等
  出版事項: (2020)
• Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
  著者:: Takemoto, Shinnosuke, 等
  出版事項: (2017)